期刊文献+

细胞穿透肽在肿瘤治疗中的研究进展 被引量:1

Research advances on cell penetrating peptides in cancer therapy
下载PDF
导出
摘要 生物技术的发展使人们意识到生物大分子物质在疾病治疗中的重要作用,如DNA,RNA,肽,蛋白质等。但是,这些生物大分子的治疗效果在很大程度上取决于它们穿过细胞膜的效率。因此,人们迫切需要找到一种可以跨越细胞膜,直接将治疗性生物大分子物质运输到细胞内相应位置的手段。在过去几十年,人们发现一种小于30个氨基酸的短肽,能够将与之相连的生物分子在体内或体外的环境下带入细胞,称为细胞穿透肽(cell penetrating peptides,CPPs)。本文主要讨论CPPs跨膜转运体系的分类和机制,以及它在肿瘤治疗中的作用。 Recent advances in biotechnology give much importance to the various therapeutic biomacromolecules,such as DNA,RNA,peptides,proteins.However,their therapeutic efficiency lies greatly on the ability of crossing cell membrane barrier.Therefore,significant effort is being made to develop agents which can overcome this barrier and directly deliver therapeutic molecules into cellular compartment.Over the past decades,a promising short oligopeptides(fewer than 30 residues),known as cell penetrating peptides(CPPs),has made it possible to transduce biological molecules into living cells in vitro and in vivo by conjugating CPPs to desired molecules.Here,we will give an extensive review on the classification and mechanism of CPPs,with particular focus on their application in cancer therapy.
作者 周洲 朱金水
出处 《现代肿瘤医学》 CAS 2010年第12期2497-2500,共4页 Journal of Modern Oncology
关键词 细胞穿透肽 肿瘤 跨膜转运机制 cell penetrating peptides cancer mechanism of membrane translocation
  • 相关文献

参考文献28

  • 1Green M,Loewenstein PM.Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein[J].Cell,1988,55(6):1179-1188. 被引量:1
  • 2Fawell S,Seery J,Daikh Y,et al.Tat-mediated delivery of heterologous proteins into cells[J].Proc Natl Acad Sci USA,1994,91(2):664-668. 被引量:1
  • 3Bres V,Tagami H,Peloponese JM,et al.Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF[J].Embo J,2002,21(24):6811-6819. 被引量:1
  • 4Lindgren ME,Hallbrink MM,Elmquist AM,et al.Passage of cell-penetrating peptides across a human epithelial cell layer in vitro[J].Biochem J,2004,377(Pt 1):69-76. 被引量:1
  • 5Deshayes S,Plenat T,Aldrian-Herrada G,et al.Primary amphipathic cell-penetrating peptides:structural requirements and interactions with model membranes[J].Biochemistry,2004,43(24):7698-7706. 被引量:1
  • 6Kim D,Jeon C,Kim JH,et al.Cytoplasmic transduction peptide (CTP):new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo[J].Exp Cell Res,2006,312(8):1277-1288. 被引量:1
  • 7Cai SR,Xu G,Becker-Hapak M,et al.The kinetics and tissue distribution of protein transduction in mice[J].Eur J Pharm Sci,2006,27(4):311-319. 被引量:1
  • 8Takeuchi T,Kosuge M,Tadokoro A,et al.Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate[J].ACS Chem Biol,2006,1(5):299-303. 被引量:1
  • 9Sakai N,Takeuchi T,Futaki S,et al.Direct observation of anion-mediated translocation of fluorescent oligoarginine carriers into and across bulk liquid and anionic bilayer membranes[J].Chembiochem,2005,6(1):114-122. 被引量:1
  • 10Noguchi H,Matsumoto S.Protein transduction technology offers a novel therapeutic approach for diabetes[J].J Hepatobiliary Pancreat Surg,2006,13(4):306-313. 被引量:1

同被引文献35

  • 1Patel L N, Zaro J L, Shen W C. Cell penetrating peptides., intracellular pathways and pharmaceutical perspectivesI-J3. Pharmaceutical Research, 2007, 24 (11) : 1977-1992. 被引量:1
  • 2Frankel A D, Pabo C O. Cellular uptake of the tat protein from human immunodefieieney virus~J]. Cell, 1988,55 (6) : 1189-1193. 被引量:1
  • 3Lundin P, Johansson H, Guterstam P, et al. Distinct uptake routes of cell-penetrating peptide conjugates EJ]. Bioconjugate Chemistry, 2008, 19 (12): 2535- 2542. 被引量:1
  • 4Drin G,Cottin S, Blanc E, et al. Studies on the inter- nalization mechanism of cationic cell-penetrating pep- tides[J]. Journal of Biological Chemistry, 2003,278 (33) .. 31192-31201. 被引量:1
  • 5Letoha T, Keller-Pint~r A, Kusz E, et al. Cell-pene- trating peptide exploited syndecans F J]. Biochim et Biophysica Acta, 2010,1798(12) : 2258-2265. 被引量:1
  • 6Subrizi A,Tuominen E, Bunker A, et al. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosamino- glycans inhibit its cellular uptake[J]. Journal of Con- trolled Release, 2012,158(2) : 277-285. 被引量:1
  • 7Tiinnemann G, Martin R M, Haupt S, et al. Cargo- dependent mode of uptake and bioavailability of TAT- containing proteins and peptides in living cells EJ]. Faseb Journal,2006,20(11) : 1775-1784. 被引量:1
  • 8Rousselle C, Clair P, Lefauconnier J M, et al. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vectormediated strategy[J]. Molecular Pharmacology, 2000, 57 (4) : 679-686. 被引量:1
  • 9Rousselle C, Smirnova M, Clair P, et al. Enhanced delivery of doxorubicin into the brain via a peptide- vectormediated strategy., saturation kinetics and spe- cificity[J]. Journal of Pharmacology and Experimental Therapeutics, 2001,296(1) : 124-131. 被引量:1
  • 10Liang J F,Yang V C. Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity[J]. Bioorganic ~ Medicinal Chemistry Let- ters, 2005,15 (22) : 5071-5075. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部